... drug selection marker is likely to enhance the in vivo efficacy of our stem cell gene therapy approach in treating HIV/AIDS. 1 The current standard of care is combinatorial antiretroviral therapy which consists of a cocktail of small molecule drugs ...
http://ift.tt/1heSTZt
http://ift.tt/1heSTZt
No comments:
Post a Comment